MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$2,835K
Free Cash flow
$32,378K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Repayment of loan principal
Accounts payable, accrued and ot...
Amortization of premiums and dis...
Others
Negative Cash Flow Breakdown
Maturities of marketable securit...
Stock-based compensation
Other assets
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-03-31
2025-09-30
2025-06-30
Net loss
35,731
-11,227
-30,260
Depreciation and amortization
-674
227
494
Stock-based compensation
-6,683
2,136
5,200
Amortization of premiums and discounts on marketable securities
-1,769
494
1,275
Amortization of debt discount and issuance costs and other non-cash interest
-238
37
201
Impairment loss of right-of-use asset
-
0
0
Loss on fixed asset write-off
119
-
-
Reclassification of currency translation loss
-
282
-
Gain on sale of nonfinancial asset
1,000
-
-
Gain on disposition of fixed assets
5
4
-
Prepaid expenses and other current assets
-1,042
432
-1,390
Other assets
2,415
-674
-1,741
Accounts payable, accrued and other current liabilities
3,908
-426
-6,322
Operating lease assets and liabilities
-1,098
603
1,154
Net cash used in operating activities
32,370
-9,830
-29,985
Purchases of property and equipment
-8
0
8
Proceeds from sale of nonfinancial asset
1,000
-
-
Proceeds from sale of fixed assets
520
9
-
Purchases of marketable securities
-
14,297
28,334
Maturities of marketable securities
-83,481
30,000
53,481
Net cash provided by investing activities
-39,322
15,712
25,139
Repayment of loan principal
-3,913
1,305
2,608
Proceeds from issuance of common stock under employee stock incentive plans
232
0
35
Net cash provided by (used in) financing activities
4,145
-1,305
-2,573
Effect of exchange rate changes on cash and cash equivalents
-28
-9
37
Net decrease in cash and cash equivalents
-2,835
4,568
-7,382
Cash and cash equivalents at the beginning of period
38,935
41,749
-
Cash and cash equivalents at the end of period
66,229
38,935
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net loss
$35,731K
Repayment of loan
principal
-$3,913K
Proceeds from issuance of
common stock under...
$232K
Accounts payable,
accrued and other...
$3,908K
Amortization of premiums and
discounts on marketable...
-$1,769K
Operating lease assets and
liabilities
-$1,098K
Prepaid expenses and
other current assets
-$1,042K
Net cash used in
operating activities
$32,370K
Net cash provided by
(used in) financing...
$4,145K
Canceled cashflow
$11,015K
Net decrease in cash
and cash...
-$2,835K
Canceled cashflow
$36,515K
something is missing
$42,631K
Proceeds from sale of
nonfinancial asset
$1,000K
Proceeds from sale of
fixed assets
$520K
Purchases of property and
equipment
-$8K
Stock-based compensation
-$6,683K
Other assets
$2,415K
Gain on sale of
nonfinancial asset
$1,000K
Depreciation and
amortization
-$674K
Amortization of debt discount
and issuance costs...
-$238K
Gain on disposition
of fixed assets
$5K
Net cash provided by
investing activities
-$39,322K
Canceled cashflow
$44,159K
Effect of exchange rate
changes on cash and cash...
-$28K
Maturities of marketable
securities
-$83,481K
Buy us a coffee
Kezar Life Sciences, Inc. (KZR)
Kezar Life Sciences, Inc. (KZR)